Weekly Research Update: Fungal Diagnostics

Posted on by

Period covered: last 7 days

Key points

  • Metagenomic next-generation sequencing (mNGS), artificial intelligence-assisted microscopy, and whole genome sequencing were among the most important fungal diagnostic themes this week.
  • Several papers reinforced the growing importance of antifungal susceptibility testing, particularly for Candida species and resistant infection.
  • Rare and specialist infections, including ocular fungal disease caused by Penicillium-like fungi, remain diagnostically challenging and often require expert input.
  • Emerging diagnostics are moving beyond simple organism detection towards faster, more precise, and more data-rich approaches.
  • Long-term surveillance and microbiome-informed studies continue to improve understanding of where diagnostic strategies may need to adapt.

This week’s fungal diagnostics update highlights a clear direction of travel: diagnosis is moving beyond conventional culture towards faster, more precise, and more data-rich approaches. Metagenomic next-generation sequencing, artificial intelligence-assisted microscopy, whole genome sequencing, and rapid susceptibility platforms all feature strongly. Alongside these advances, several papers reinforce the ongoing importance of species identification, antifungal susceptibility testing, and specialist input in complex or unusual fungal infections.

Contents

Top highlights

1. Metagenomic sequencing continues to show value in difficult-to-diagnose infection

Wang C, Min M, Dai Z, Wang G, Wang Y, Hu T, Ma Y, Zhang S, Wu C, Zhou R.
Diagnostic value of metagenomic next-generation sequencing in patients with febrile lung cancer with negative conventional microbiological tests and without neutropenia.

This paper stands out as one of the most clinically relevant diagnostic studies this week. It supports the growing role of metagenomic next-generation sequencing (mNGS) in patients where standard microbiological testing is negative but infection remains strongly suspected. This is especially important in complex respiratory patients and in those whose presentation may not fit traditional high-risk categories. The wider message is that mNGS is becoming an increasingly important adjunct when conventional diagnostic pathways do not provide an answer.

2. Single-cell antifungal susceptibility testing points towards much faster precision diagnostics

Han X, Zhang Y, Zheng X, Wang X, Chen R, Liu M, Yang Q, Huang G, Fu YV, Ma B, Huang J, Xu J.
Antifungal Susceptibility Test via Single-Cell Morphology, Development, and Metabolism. PubMed: 41896031

This is one of the most interesting technology papers of the week. Rather than waiting for conventional growth-based susceptibility testing, this method examines fungal response at single-cell level. If developed further, approaches like this could shorten the time needed to identify whether an isolate is likely to respond to treatment. That would be particularly valuable for invasive fungal disease, where delays in appropriate therapy can have major consequences.

3. Whole genome sequencing strengthens outbreak investigation and resistance detection in Candida auris

Murphy SG, Ross T, Fitzgerald A, Gauthier NPG, Keller E, Barker E, Memon W, Chorlton SD, Moore T, Curless MS, Fabre V, Maragakis LL, Simner PJ, Zhang SX.
Detecting healthcare-associated transmission and antifungal resistance in Candida auris via whole genome sequencing. PubMed: 41879325

This paper shows how whole genome sequencing is increasingly useful not only for research, but for practical clinical microbiology and infection prevention. In Candida auris, a pathogen that raises major concern because of hospital transmission and frequent antifungal resistance, sequencing can help identify both outbreak links and resistance patterns. This is an important example of diagnostic microbiology and infection control becoming more tightly integrated.

4. Artificial intelligence plus mobile microscopy may expand access to fungal diagnosis

Pongpom M, Sookkhee S, Chongkae S, Wattanasombat S, Pikulkaew K, Lawan N, Upaphong P, Wangsanut T.
Fungal recognition in vaginal discharge using deep learning analysis of mobile device-acquired microscopic images.

This study illustrates how digital diagnostics may widen access to fungal testing. By applying deep learning to microscope images captured using a mobile device, the authors move towards a lower-cost and potentially more scalable model of fungal recognition. Although focused on a specific setting, the broader message is important: artificial intelligence-supported image analysis may help bring fungal diagnostics closer to the point of care.

Emerging and enabling diagnostic technologies

Electrochemical biosensing platforms for rapid detection

Zheng Y, Fu L, Yang J, Gao S, Sun H, Zhang F.
Electrochemical Biosensing Platforms for Rapid and Early Diagnosis of Crop Fungal and Viral Diseases. PubMed: 41902172

This paper is outside direct human medicine, but the technology is relevant. Biosensor platforms are attractive because they may deliver faster detection than conventional culture while maintaining good sensitivity. Even when early work is done in plant disease or agricultural settings, the underlying diagnostic principles often have wider relevance.

Blood culture process optimisation still matters

Wang L, Yang F, Zhou C, Yang X, Rong J, Chi X, Guo R, Li N, Sheng L, Jiang L, Zhao Q, Yi M.
Multifactorial impacts of blood culture process optimization on clinical outcomes and healthcare economics in bloodstream infection management.

New technologies are important, but this paper is a useful reminder that diagnostic quality also depends on system performance. Improvements in blood culture workflows can affect yield, turnaround time, downstream treatment, and cost. For fungal bloodstream infection, where diagnostic sensitivity can already be limited, getting the fundamentals right remains essential.

Risk phenotyping from electronic health records may improve targeting of fungal diagnostics

Riera-Arnau J, Luxi N, Riefolo F, Solorzano M, Pazos I, Ballarín E, Svingel L, Chiusaroli L, Martín-Merino E, Barbieri E, Lopez-Lasanta M, Mohammadi S, Rotta D, Pacurariu A, Cohet C, Sturkenboom M, Durán C.
Immunocompromised Status Definition in Observational Studies Using Electronic Health Records: A Scoping Review and a Proposal for a Phenotype Identification Algorithm.

This is not a fungal diagnostic test paper, but it is relevant to diagnostic strategy. Better identification of who is truly immunocompromised may help clinicians and systems decide who needs earlier or broader fungal investigation. In practice, better case finding often begins with better risk recognition.

Artificial intelligence tools may eventually support infection-related decision making

Escudero-Arnanz O, Valero-Méndez ME, Sánchez-Ramos N, Soguero-Ruíz C.
Evaluation of a Retrieval-Augmented Generation Chatbot for Antimicrobial Resistance Research: Comparative Analysis of Large Language Models. PubMed: 41875309

This paper is not focused specifically on fungal disease, but it contributes to the wider picture of how artificial intelligence tools may be used to help clinicians and researchers navigate rapidly growing antimicrobial evidence. In future, such tools may support diagnostic interpretation, evidence retrieval, or resistance-related decision support, provided they are carefully validated.

Clinical and epidemiological findings that support diagnosis

Long-term Candida surveillance reinforces the need for species-level diagnosis

Ji Y, Gao S, Zhang Y, Zhang Z, Liu C, Shen H, Zhou W.
Species distribution and antifungal susceptibility of Candida isolates from sterile body sites: a 14-year retrospective study at a tertiary care hospital in China (2010–2023). PubMed: 41876998

Long-term surveillance studies like this matter because they show how species distributions and susceptibility patterns change over time. For clinical practice, the implication is straightforward: it is increasingly unsafe to assume that all Candida behave alike. Accurate identification to species level, and susceptibility testing where appropriate, remain essential.

High azole resistance in non-albicans Candida underlines the need for routine susceptibility testing

Idrissa SA, Ishimwe MPS, Kasujja M, Nteziyaremye T, Liban S, Osman YA, Shem K, Okello M, Kajabwangu R, Hakizimana T.
High azole resistance among non-albicans Candida species causing vulvovaginal candidiasis in Western Uganda: a cross-sectional study. PubMed: 41870870

This study reinforces a theme seen repeatedly across fungal diagnostics: knowing that a fungus is present is often not enough. If resistance is common, then susceptibility information becomes much more important. The findings support a more precise approach to recurrent or treatment-resistant disease.

Persistent candidemia in children: diagnostic vigilance remains important

Siqueira AC, Ferreira AMM, Silva SCSB, Sestren B, Krul D, de Andrade DP, Poubel SDB, Spalanzani RN, Ricieri MC, Motta FDA, Svidzinski TIE, Rodrigues LS, Dalla-Costa LM.
Persistent candidemia in pediatrics: exploring risk factors. PubMed: 41862170

Although mainly a clinical risk-factor study, this paper has diagnostic implications. Patients at higher risk of persistent candidemia are likely to need closer microbiological follow-up, repeat cultures, careful source investigation, and timely reassessment of antifungal strategy.

Malassezia susceptibility data broaden the diagnostic picture beyond Candida and Aspergillus

de Pádua Oliveira D, Possa A, de Oliveira Santos A, Borges A, Cisalpino P, Vilela R, Rosa C, Johann S.
Diversity and Antifungal Susceptibility of Malassezia spp. Isolated From Brazilian Patients With Pityriasis Versicolor and Seborrheic Dermatitis. Free full text (PMCID: PMC13032048)

This paper reminds us that fungal diagnostics is broader than invasive moulds and candidemia. Better understanding of Malassezia diversity and susceptibility may improve interpretation in dermatology and help refine management where disease is recurrent or difficult to control.

The vaginal microbiome may become part of future candidiasis diagnostics

Consuegra-Asprilla JM, Cuesta-Astroz Y, González Á.
Characterization of the vaginal microbiome and its metabolic potential in Colombian patients with recurrent vulvovaginal candidiasis. PubMed: 41880538

This is a useful reminder that diagnosis is not always about detecting one organism in isolation. In recurrent vulvovaginal candidiasis, broader microbiome context may help explain why disease persists or recurs. Over time, this may support more nuanced diagnostic models that combine fungal detection with wider ecological information.

Specialist and niche diagnostic relevance

Ten years of ocular fungal infections due to Penicillium-like fungi in France

Monpierre L, Dannaoui E, Lortholary O, Boukris-Sitbon K, Merabet L, Chouaki T, Pihet M, Millon L, Delhaes L, Bonhomme J, Cateau E, Dalle F, Cardot E, Desbois-Nogard N, Nicolas M, Sasso M, Recalt E, Alanio A, Gangneux JP, … Botterel F.
A decade of ocular fungal infections due to Penicillium-like fungi in France (2012 to 2021). PubMed: 41880484

This is one of the most important specialist papers in the update. Rare or unusual ocular fungal infections can be very difficult to diagnose, and this study highlights the need for specialist mycology expertise, careful laboratory work, and an awareness that uncommon moulds can be clinically significant. It also reminds us that where the pathogen is unusual, delays in diagnosis may be especially likely.

Echinocandins in Candida albicans endophthalmitis

Zhang Y, Tang Y, Zhou Y, Wu H.
Safety and efficacy of echinocandin antifungal agents in Candida albicans endophthalmitis. PubMed: 41870115

This is mainly a treatment-focused paper, but it still has diagnostic relevance. Ocular fungal infections often need rapid recognition, correct species identification, and close collaboration between ophthalmology, microbiology, and infectious diseases. Treatment questions cannot be separated from diagnostic accuracy in this setting.

Resistance biology in Candida glabrata may affect how resistance is interpreted

Arastehfar A, Daneshnia F, Hovhannisyan H, Cabrera N, Jusuf S, Salehi M, Mansour MK, Gabaldón T, Shor E, Perlin DS.
Multidimensional assessment of in-host fitness costs of echinocandin resistance in the opportunistic fungal pathogen Candida glabrata reveals the niche-specific requirement for FKS1 and FKS2 during infection and gut colonization. PubMed: 41870047

This is a mechanistic resistance paper rather than a clinical diagnostic paper, but it is relevant because it adds depth to how resistance mutations may behave in different host environments. Over time, studies like this may improve interpretation of resistance testing and help explain why laboratory findings do not always translate neatly into clinical behaviour.

Background science with possible future diagnostic relevance

Stress responses, tolerance, and virulence in Candida albicans

Xi B, Wu Y.
Peroxin Pex8 couples stress responses, antifungal tolerance, and virulence regulation in Candida albicans. PubMed: 41874383

This paper is mainly basic science, so it is not a front-line diagnostic highlight. However, work of this kind can help identify pathways that may later serve as biomarkers, therapeutic targets, or explanations for why some fungal infections are harder to detect or treat than others.

What this means

1. Fungal diagnostics are becoming faster and more precise.
The strongest papers this week point towards a future in which diagnosis depends less on slow culture alone and more on combined molecular, genomic, and digital approaches.

2. Diagnostic microbiology and infection control are increasingly linked.
Whole genome sequencing is a good example of how one test platform can support both patient diagnosis and outbreak investigation.

3. Susceptibility testing remains central.
Resistance continues to shape the field, especially in Candida. This means that identifying the organism is only part of the job; understanding likely drug response is increasingly important too.

4. Rare fungi still need specialist awareness.
The ocular infection paper is a reminder that uncommon fungal pathogens do occur, and that specialist input remains essential when standard assumptions do not fit the case.

5. The future is likely to be multi-layered.
The next generation of fungal diagnostics may combine organism detection, susceptibility testing, genomic epidemiology, host risk profiling, and, in some settings, microbiome context.

References and links